Literature DB >> 6214046

Identity of ultrastructural effects of mercuric chloride and methyl mercury after intracerebral injection.

P J Gallagher, J Mitchell, H V Wheal.   

Abstract

In man the clinical patterns of inorganic and organic mercury toxicity are different. Inorganic mercuric chloride mainly affects the renal and gastrointestinal systems. The characteristic neurological feature is a fine tremor, particularly of the hands and fingers. In contrast organic methyl mercury toxicity results in an exclusively neurological disorder, the characteristic features being ataxia, dysarthria, paresthesia and tunnel vision. To study the action of these classes of mercury compounds on neurones small amounts of mercuric chloride or methyl mercuric acetate were injected or iontophoresed into the rat cerebrum. The ultrastructural changes which followed were identical. Progressive and often pronounced cytoplasmic swelling of neurones suggested a defect at the cell membrane level. Thus is spite of their distinctive clinical syndromes these 2 classes of mercury compounds are capable of inducing neuronal necrosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214046     DOI: 10.1016/0300-483x(82)90103-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  2 in total

1.  Changes of the Na/K ATPase activity in the cerebral cortical microvessels of rat after single intraperitoneal administration of mercuric chloride: histochemical demonstration with light and electron microscopy.

Authors:  G Szumańska; R Gadamski; J Albrecht
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

2.  Evaluation of the effects of chronic intoxication with inorganic mercury on memory and motor control in rats.

Authors:  Francisco B Teixeira; Rafael M Fernandes; Paulo M A Farias-Junior; Natacha M M Costa; Luanna M P Fernandes; Luana N S Santana; Ademir F Silva-Junior; Marcia C F Silva; Cristiane S F Maia; Rafael R Lima
Journal:  Int J Environ Res Public Health       Date:  2014-09-05       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.